Chrysalis Ventures Managing Director Koleman Karleski to Participate in NVCA M&A Webcast

Louisville, KY, April 7, 2010Koleman Karleski, Managing Director at Chrysalis Ventures will participate as a panelist on the April 9th webcast titled, “Evolving Trends for Venture Backed M&A Transactions” sponsored by the National Venture Capital Association and Proskauer Rose LLP. Karleski will be joined by Paul Ciriello, Partner, Fairhaven Capital; Sarah Reed, General Counsel, Charles River Ventures; James Wilder, Director, Housatonic Partners; and Alexander Temel, Partner, Proskauer Rose LLP as moderator.

Recently, Karleski has counseled two healthcare portfolio companies through the M&A exit process. In December 2009, MedServe was sold to Stericycle and in October 2008, HealthMedia was sold to Johnson & Johnson.

Click here to register for the webcast.

About Chrysalis Ventures

Founded in 1993, Chrysalis Ventures manages one of Mid-America’s largest funds for early-stage and growth investments with approximately $400 million under management. Focused on partnering with entrepreneurs to build enduring businesses in industries undergoing significant transformation, Chrysalis has invested in over 65 companies primarily in the Healthcare and Technology sectors. Headquartered in Louisville, KY, Chrysalis has offices in Cleveland, Pittsburgh and Ann Arbor. For more information, please visit www.chrysalisventures.com.